Brazil Joins Kenya to Urge Global Fund for Neglected Diseases

The governments of Brazil and Kenya plan to propose the creation of an international fund to stimulate research on medicines to combat the so-called neglected diseases, which affect poor populations and, according to the World Health Organization (WHO), kill more than 35,000 people daily around the world.

This measure is part of a resolution proposal that will be presented by the president of the Osvaldo Cruz Foundation (Fiocruz), Paulo Buss, at the annual meeting of the WHO next month in Geneva, Switzerland.

The purpose of the proposal is to enlist the support of the 192 member countries of the WHO behind a global commitment to foment research that will lead to medicines and other solutions (such as vaccines and diagnostic kits) for this type of disease.

"These are the diseases that strike the world’s poorest areas and, because they do not interest the pharmaceutical industry, which cherishes profits, do not attract research investments," Buss observed.

Malaria, leishmaniasis, leprosy, (Hansen’s disease), tuberculosis, sleeping sickness, and Chagas’ disease are on the list of neglected diseases. All of them are typical of tropical areas, and their victims are overwhelmingly poor.

According to Buss, the remedies used to treat them are antiquated and ineffective. "No one is doing research in this area the way it should be done, with investment backing."

He pointed out that the world should heed the fact that "only 10% of research outlays go to diseases that affect 90% of the population."

In his view, there is an inversion in what is spent on research, which only focuses on certain problems, "generally the ones that exist in the developed countries and produce bigger profits."

The proposal was presented in Rio, Wednesday, April 5, at a panel organized by the Drugs for Neglected Diseases Initiative (DNDI), an international non-governmental organization devoted to health research and development.

The DNDI’s members include health research institutes from all over the world, such as the Fiocruz, in Brazil, and the Pasteur Institute, in France.

Agência Brasil

Tags:

  • Show Comments (1)

  • Guest

    Good News for a change. This joint partnership is respected – and exiting developments should emerge.

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

Arabs Start Push to Deliver Thousands of Korans to Brazilian Elite

The version of the Koran in Portuguese, translated by professor Helmi Mohammed Ibraim Nasr, ...

World’s Number 1: 43% of Censorship in Google Comes from Brazil

Brazil has a big lead as the country with the most government requests to ...

Brazil Learns About Prison Alternatives in the UK

Brazil’s Minister of Justice, Márcio Thomaz Bastos, said that the cooperation agreement with the ...

Boeing 777-300ER with the TAM logo

Brazil’s TAM Becomes First LatAm Carrier to Fly the Boeing 777-300ER

Brazil's largest airline TAM and American aircraft manufacturer Boeing announced today  conclusion of a ...

Fearing Inflation, Brazil Raises Interest Rates to 17.75%

Inflation Brazilian markets ended modestly higher, helped by some modest gains on Wall Street. ...

Even if Slowly Jobs Continue to Expand in Brazil

Brazil’s government statistical bureau (IBGE) has released data for January showing that job growth ...

Brazil: UN Has Project to Rescue the Amazon

With the environment of the Amazon Basin increasingly under siege from deforestation, mining, urbanization ...

Why Is Brazil Afraid Vice Alencar Will Become President?

A common denominator unites all the political, business and union forces in Brazil: the ...

Brazilian University Starts Cooperation with African Schools

The University of Manouba, in Tunisia, is interested in projects for special education developed ...

Brazil: The Transgenics Dilemma

The Brazilian Congress is divided over the issue of cultivation and sale of transgenics ...